# NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

> **NCT03603652** · NA · TERMINATED · sponsor: **Ethicon, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Cancer of Lung
- Cancer of the Lung
- Lung Cancer
- Neoplasms, Lung
- Carcinoma, Non-Small Cell Lung
- Non-Small Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma

## Interventions

- **DEVICE:** Microwave Ablation

## Key facts

- **NCT ID:** NCT03603652
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-29
- **Primary completion:** 2018-12-21
- **Final completion:** 2019-10-24
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study originally suspended pending a protocol amendment but study now terminated.
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603652, "NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03603652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*